EUVIMEDEUVIMED entdecken
Crossref

Atorvastatin calcium alleviates 5-fluorouracil-induced intestinal damage by inhibiting cellular senescence and significantly enhances its antitumor efficacy

Jing Xia, Siyue He, Qianlong Dai, Huijie Jia, Yuchen Ge, Min Zhou, Xiaobo Wang

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Jing Xia und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Dali University, Dali, Yunnan, 671000, China; Key Laboratory of University Cell Biology Yunnan Province, Dali, Yunnan, 6710…. Hauptthemen laut MEDLINE: Fluorouracil, Colorectal Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

5-Fluorouracil (5-Fu) is the preferred drug in colorectal cancer treatment. Although 5-Fu treatment contributes to the increase in survival rates, long-term use of 5-Fu causes severe intestinal damage, eventually decreasing long-term survival. There is no standardtreatmentfor intestinal damage induced by 5-Fu. Our previous study found that 5-Fu-induced intestinal damage was connected to an increase in senescent cells, and antiaging drugs could relieve some adverse side effects caused by 5-Fu. Hence, it is essential to discover novel, potential antiaging therapeutic drugs for 5-Fu side effect treatment. According to the current study, Atorvastatincalcium (Ator) alleviated cellular senescence in human intestinal epithelial cells (HUVECs) and human umbilical vein endothelial cells (HIECs) caused by oxidative stress and 5-Fu. 5-Fu resulted in an increase in SA-β-Gal-positive cells, synchronously increased expression of aging-related proteins (p16), aging-related genes (p53, p21), and the senescence-associated secretory phenotype (SASP: IL-1β, IL-6, TNF-α), while Atorvastatincalcium (Ator) reversed the increase in these indicators. In the BALB/c mouse model, we confirmed that intestinal damage caused by 5-Fu is related to the increase in senescent cells and drug-induced inflammation, with the therapeutic effects of Ator. In addition, Ator increased the sensitivity of 5-Fu to chemotherapy in vitro and in vivo. Combination therapy significantly reduced HCT116 cell viability. Furthermore, Ator and 5-Fu present a cooperative effect on preventing the growth of tumors in CRC xenograft nude mice. In conclusion, our study demonstrates the value of Ator for treating intestinal damage. Moreover, Ator combined with 5-Fu increased the antitumor ability in CRC cells. Additionally, we provide a novel therapeutic protocol for CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluorouracilColorectal NeoplasmsMiceAnimalsHumansAtorvastatinMice, NudeEndothelial CellsCellular Senescence

Stichwörter der Autor:innen

5-FluorouracilAtorvastatincalciumColorectal cancerIntestinal damageSenescence

Substanzen

FluorouracilAtorvastatin

Autor:innen und Institutionen

  • School of Basic Medicine, Dali University, Dali, Yunnan, 671000, China; Key Laboratory of University Cell Biology Yunnan Province, Dali, Yunnan, 671000, China.
  • School of Basic Medicine, Dali University, Dali, Yunnan, 671000, China; Key Laboratory of University Cell Biology Yunnan Province, Dali, Yunnan, 671000, China. Electronic address: 252862918@qq.com.
  • School of Basic Medicine, Dali University, Dali, Yunnan, 671000, China; Key Laboratory of University Cell Biology Yunnan Province, Dali, Yunnan, 671000, China. Electronic address: wxb4320062@163.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xia, J., He, S., Dai, Q., Jia, H., Ge, Y., Zhou, M., & Wang, X. (2023). Atorvastatin calcium alleviates 5-fluorouracil-induced intestinal damage by inhibiting cellular senescence and significantly enhances its antitumor efficacy. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110465

Vancouver

Xia J, He S, Dai Q, Jia H, Ge Y, Zhou M, et al. Atorvastatin calcium alleviates 5-fluorouracil-induced intestinal damage by inhibiting cellular senescence and significantly enhances its antitumor efficacy. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110465

BibTeX
@article{Xia2023,
  author = {Xia, Jing and He, Siyue and Dai, Qianlong and Jia, Huijie and Ge, Yuchen and Zhou, Min and Wang, Xiaobo},
  title = {Atorvastatin calcium alleviates 5-fluorouracil-induced intestinal damage by inhibiting cellular senescence and significantly enhances its antitumor efficacy},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110465}
}
Kostenlos starten →